Lyell Immunopharma Inc (LYEL) — Free Cash Flow Generation Index
Lyell Immunopharma Inc (LYEL) has a Free Cash Flow Generation Index of 0.59x as of December 2019. Free cash flow of $23.43 Million represents 1% of operating cash flow ($39.47 Million). Explore Lyell Immunopharma Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Free Cash Flow Generation Index (2019–2019)
Historical FCF Generation Index trend for Lyell Immunopharma Inc across 1 annual periods. For the full cash flow conversion analysis, see LYEL cash generation efficiency.
Annual Free Cash Flow Generation for Lyell Immunopharma Inc (2019–2019)
Year-by-year Free Cash Flow Generation Index for Lyell Immunopharma Inc. Check Lyell Immunopharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.59x | $23.43 Million | $39.47 Million | $16.05 Million | — |